Fe (Ferrous / Ferric Forms)
Critical for hemoglobin synthesis, enabling red blood cells to transport oxygen throughout the body.
Supports brain oxygenation and neurotransmitter synthesis, preventing brain fog and poor concentration.
Required for myoglobin in muscles, supporting endurance and strength.
Essential for immune cell proliferation and function.
Vitamin C (ascorbic acid) converts iron to more absorbable ferrous form and prevents precipitation in the gut.
Only supplement if deficiency is confirmed via blood work (ferritin, serum iron, TIBC). Ferrous forms (sulfate, gluconate, bisglycinate) absorb better than ferric. Take with vitamin C to enhance absorption; avoid with calcium, tea, or coffee. Start low to assess tolerance.
Iron Fact Sheet for Health Professionals
Iron: Research Summary
Not all forms absorb equally — these are ordered best-absorbed first.
Chelated form — well absorbed with noticeably less nausea and constipation than iron salts.
The standard, effective and inexpensive, but commonly causes constipation or nausea.
Gentler than sulfate but carries less elemental iron per tablet, so doses run larger.
Ferric forms absorb far less well than ferrous ones.
Absorption varies between people; informational only, not medical advice.
What the evidence says — with links to the original studies
There is strong, authoritative consensus that oral iron supplementation is effective and warranted for treating and preventing confirmed iron deficiency and iron-deficiency anemia, but it should not be taken routinely without a documented need because of common GI side effects. Ferrous (Fe2+) salts are more bioavailable than ferric (Fe3+) salts, and controlled-isotope studies (Stoffel/Moretti) show that lower or alternate-day dosing raises fractional absorption by transiently lowering hepcidin. Vitamin C reliably enhances non-heme iron absorption in isolated studies, but a randomized clinical trial found it adds no meaningful clinical benefit over iron alone for treating anemia. Newer chelated forms such as ferrous bisglycinate show comparable or better efficacy at lower elemental doses with fewer GI complaints in some populations.
Authoritative reference. States ferrous iron is more bioavailable than ferric iron; ascorbic acid enhances non-heme absorption; high doses (>=45 mg/day) cause GI upset; lists groups at risk of deficiency who may warrant supplementation.
Alternate-day dosing gave higher fractional absorption (21.8% vs 16.3%) and greater cumulative absorption; daily and twice-daily dosing raised hepcidin, suppressing next-dose absorption.
Extends findings to anemic (not just depleted) women; fractional absorption 40-50% higher on alternate days; hepcidin rise persists ~24h, suppressing absorption the following day.
57 trials, 48,971 women. Iron probably reduces maternal iron-deficiency anemia at term (moderate-certainty); reductions in anemia and iron deficiency were low-certainty.
43 RCTs, 6,831 adults. Ferrous sulfate roughly doubled GI side effects vs placebo (OR 2.32, 95% CI 1.74-3.08); no significant dose-response, so lower doses did not clearly reduce risk.
Iron alone was equivalent to iron plus vitamin C for hemoglobin and ferritin response; concluded vitamin C is not essential when treating IDA with oral iron.
In pregnant women, ferrous bisglycinate raised hemoglobin more than comparators (often ferrous sulfate) at lower elemental doses, with fewer GI side effects (IRR 0.36); no clear benefit in children.
Opposes the common claim that co-administered vitamin C meaningfully improves clinical outcomes of oral iron therapy; found no added clinical benefit over iron alone.
Educational summary of published research — not medical advice. Consult a qualified professional before supplementing.
Join our collective laboratory. Share your experience level with this topic and help others gauge the journey.
Based on .
No one has shared yet. Be the first to place a pin on the map.
check_circle You marked yourself as .
Status: In Your Stack Status: Not in Stack